C. Lacalle-González (Medical Oncologist) , A. Estrella Santos (Endocrinologist) , L.C. Landaeta Kancev (Nuclear Medicine Physician) , V.M. Castellano (Pathologist) , E. Macia Palafox (Cardiologist) , A. Paniagua Ruíz (Endocrinologist) , J. Luna Tirado (Radiation Oncologist) , B. Martínez-Amores (Medical Oncologist) , L. Martínez Dhier (Nuclear Medicine Physician) , A. Lamarca (Medical Oncologist)
{"title":"神经内分泌肿瘤非肝远处转移的处理。","authors":"C. Lacalle-González (Medical Oncologist) , A. Estrella Santos (Endocrinologist) , L.C. Landaeta Kancev (Nuclear Medicine Physician) , V.M. Castellano (Pathologist) , E. Macia Palafox (Cardiologist) , A. Paniagua Ruíz (Endocrinologist) , J. Luna Tirado (Radiation Oncologist) , B. Martínez-Amores (Medical Oncologist) , L. Martínez Dhier (Nuclear Medicine Physician) , A. Lamarca (Medical Oncologist)","doi":"10.1016/j.beem.2023.101784","DOIUrl":null,"url":null,"abstract":"<div><p><span>Neuroendocrine neoplasms represent an uncommon disease with an increasing incidence. Thanks to improvements in diagnostic and therapeutic methods, metastases previously considered uncommon, such as </span>bone metastases<span>, or even very rare, such as brain, orbital and cardiac metastases, are more frequently found in daily practice. Due to the great heterogeneity of these neoplasms, there is a lack of high-quality evidence on the management of patients with these types of metastases. The aim of this review is to provide the current state of the art, reviewing neuroendocrine neoplasm specific studies and useful information from other tumor types and to propose a treatment recommendation with algorithms to consider in daily clinical practice.</span></p></div>","PeriodicalId":8810,"journal":{"name":"Best practice & research. Clinical endocrinology & metabolism","volume":"37 5","pages":"Article 101784"},"PeriodicalIF":6.1000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Management of non-hepatic distant metastases in neuroendocrine neoplasms\",\"authors\":\"C. Lacalle-González (Medical Oncologist) , A. Estrella Santos (Endocrinologist) , L.C. Landaeta Kancev (Nuclear Medicine Physician) , V.M. Castellano (Pathologist) , E. Macia Palafox (Cardiologist) , A. Paniagua Ruíz (Endocrinologist) , J. Luna Tirado (Radiation Oncologist) , B. Martínez-Amores (Medical Oncologist) , L. Martínez Dhier (Nuclear Medicine Physician) , A. Lamarca (Medical Oncologist)\",\"doi\":\"10.1016/j.beem.2023.101784\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Neuroendocrine neoplasms represent an uncommon disease with an increasing incidence. Thanks to improvements in diagnostic and therapeutic methods, metastases previously considered uncommon, such as </span>bone metastases<span>, or even very rare, such as brain, orbital and cardiac metastases, are more frequently found in daily practice. Due to the great heterogeneity of these neoplasms, there is a lack of high-quality evidence on the management of patients with these types of metastases. The aim of this review is to provide the current state of the art, reviewing neuroendocrine neoplasm specific studies and useful information from other tumor types and to propose a treatment recommendation with algorithms to consider in daily clinical practice.</span></p></div>\",\"PeriodicalId\":8810,\"journal\":{\"name\":\"Best practice & research. Clinical endocrinology & metabolism\",\"volume\":\"37 5\",\"pages\":\"Article 101784\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Best practice & research. Clinical endocrinology & metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1521690X23000581\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Best practice & research. Clinical endocrinology & metabolism","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1521690X23000581","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Management of non-hepatic distant metastases in neuroendocrine neoplasms
Neuroendocrine neoplasms represent an uncommon disease with an increasing incidence. Thanks to improvements in diagnostic and therapeutic methods, metastases previously considered uncommon, such as bone metastases, or even very rare, such as brain, orbital and cardiac metastases, are more frequently found in daily practice. Due to the great heterogeneity of these neoplasms, there is a lack of high-quality evidence on the management of patients with these types of metastases. The aim of this review is to provide the current state of the art, reviewing neuroendocrine neoplasm specific studies and useful information from other tumor types and to propose a treatment recommendation with algorithms to consider in daily clinical practice.
期刊介绍:
Best Practice & Research Clinical Endocrinology & Metabolism is a serial publication that integrates the latest original research findings into evidence-based review articles. These articles aim to address key clinical issues related to diagnosis, treatment, and patient management.
Each issue adopts a problem-oriented approach, focusing on key questions and clearly outlining what is known while identifying areas for future research. Practical management strategies are described to facilitate application to individual patients. The series targets physicians in practice or training.